Xue F, Guo S, Liu P, Chen W, Chen Y, Wen Q, Hua H, Cao Y, Feng X, Sun J, Xu C, Yang R. First-in-human pharmacokinetic, safety, and preliminary efficacy studies of single- and multiple-dose FRSW117, a novel PEGylated recombinant factor VIII-Fc fusion protein with an extended half-life, in patients with severe hemophilia A. Haematologica 2025;110(11):2786-2791; https://doi.org/10.3324/haematol.2024.286964.